Covered recipient · General Payments record
MITCHAL A SCHREINER
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,254.07
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $558.37 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $220.29 | 13 |
| Gilead Sciences, Inc. | $121.85 | 1 |
| Janssen Biotech, Inc. | $45.31 | 3 |
| Celgene Corporation | $37.58 | 2 |
| Olympus America Inc. | $32.80 | 2 |
| Ardelyx, Inc. | $32.61 | 1 |
| Ipsen Biopharmaceuticals, Inc | $29.84 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.41 | 1 |
| PFIZER INC. | $16.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.55 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041292 | CMS |
| ABBVIE INC. | $17.34 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041294 | CMS |
| ABBVIE INC. | $4.77 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041296 | CMS |
| ABBVIE INC. | $10.27 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041298 | CMS |
| ABBVIE INC. | $9.87 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041300 | CMS |
| ABBVIE INC. | $9.07 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041302 | CMS |
| ABBVIE INC. | $28.37 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041304 | CMS |
| ABBVIE INC. | $29.39 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041306 | CMS |
| ABBVIE INC. | $9.27 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041308 | CMS |
| ABBVIE INC. | $8.71 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041310 | CMS |
| ABBVIE INC. | $25.28 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041312 | CMS |
| ABBVIE INC. | $25.62 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041314 | CMS |
| ABBVIE INC. | $20.78 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041316 | CMS |
| Ardelyx, Inc. | $32.61 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146706409 | CMS |
| Celgene Corporation | $23.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101127916 | CMS |
| Celgene Corporation | $13.62 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101127944 | CMS |
| Gilead Sciences, Inc. | $121.85 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133790201 | CMS |
| Ipsen Biopharmaceuticals, Inc | $29.84 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091988187 | CMS |
| Janssen Biotech, Inc. | $15.56 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078383981 | CMS |
| Janssen Biotech, Inc. | $14.87 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078384922 | CMS |
| Janssen Biotech, Inc. | $14.88 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078383997 | CMS |
| Olympus America Inc. | $16.75 | 01/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108484953 | CMS |
| Olympus America Inc. | $16.05 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108484949 | CMS |
| PFIZER INC. | $16.68 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131972177 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.41 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153620231 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.